Management of Acute Ischemic Stroke in Patients with COVID-19 Infection
Listen now
Description
On March 11th, 2020 the World Health Organization declared the COVID-19 infection a pandemic. We are currently in the throws of that global infection and the big question everyone is racing to ask and answer is the risk of ischemic stroke higher in patients with COVID-19 infection. We spoke to both Drs based in the United States Adnan Quereshi from the University of Missouri, Department of Neurology, and Vishal Jani from the Creighton University School of Medicine, Immanuel Medical Centre Omaha Nebraska, who is the corresponding author for the article “Management of Acute Ischemic Stroke in Patients with COVID-19 Infection: Report of an International Panel” This important paper is from a team of doctors on the front line from the USA, Egypt, Turkey, Iran, Italy Taiwan, Pakistan, Poland, France and China and more presents a comprehensive set of practice implications in a single document for clinicians caring for adult patients with acute ischemic stroke with confirmed or suspected COVID-19 infection.
More Episodes
Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatran treatment may become eligible for thrombolysis with rt-PA. In patients on dabigatran with intracerebral hemorrhage...
Published 08/25/20
Mobile stroke units, otherwise known as MSUs have recently been introduced in the care of patients suspected of having an acute stroke, leading to shortening in the time to thrombolytics, but how does the clinical effectiveness in terms of functional outcome and survival among patients treated in...
Published 08/19/20